Dresner Names Managing Director, Healthcare Investment Banking
Dresner Partners announced that it has named Mitchell Stern as managing director, Healthcare Investment Banking. Stern will be responsible for expanding Dresner’s healthcare and medtech practice. He will be located in New York City.
Prior to joining Dresner Partners, Stern was a managing director in the Healthcare Investment Banking Group at New York-based Morgan Joseph TriArtisan LLC, where his primary role was capital raising and merger & acquisition (M&A) transaction management in the healthcare industry.
Stern began his 20-year investment banking career at Salomon Brothers in New York, and held senior positions with Schroder & Co., Needham & Company, Glocap Advisors and SMH Capital. Stern also was a C.P.A. with Deloitte & Touche and Ernst & Whinney.
“We are very pleased to have Mitch join our firm,” said Steven M. Dresner, president of Dresner Partners. “His vast experience in the healthcare and medtech sectors will be a tremendous addition to our talented healthcare team.”
Stern has been involved in a variety of domestic and cross-border middle market capital raising and M&A transactions in the areas of medical devices, life sciences, healthcare services and healthcare IT. He also has experience in other industry segments including consumer products, technology, education and industrials. Stern holds an M.B.A. in Finance from New York University and a B.A. in Accounting from Franklin & Marshall College.
Dresner Partners is a middle-market investment bank that provides financial advisory services to business owners and managers throughout the world, including institutional private placements of debt and equity, merger and acquisitions, valuations and strategic consulting services.